Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia between 34 and 37 weeks' gestation (HYPITAT-II): a multicentre, open-label randomised controlled trial

• Main Authors: Sporken Jan M J (Author), Perquin Denise A M (Author), Franssen Maureen T M (Author), Wijnen-Duvekot Ella J (Author), Willekes Christine (Author), Oosterbaan Herman P (Author), van Huizen Marloes E (Author), van Beek Erik (Author), Groot Christianne (Author), Bloemenkamp Kitty W (Author), Oudijk Martijn A (Author), Porath Martina (Author), Groen Henk (Author), van Kaam Anton H (Author), van Pampus Maria G (Author), van Baaren Gert-Jan (Author), Broekhuijsen Kim (Author), Langenveld Josje (Author), Woiski Mallory D (Author), Bremer Henk A (Author), Papatsonis Dimitri N M (Author), Brons Jozien T J (Author), Kaplan Mesruwe (Author), Nij Bijvanck Bas W A (Author), Mol Ben-Willen J (Author)
• Format: Book
• Published: BMC, 2011-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>Gestational hypertension (GH) and pre-eclampsia (PE) can result in severe complications such as eclampsia, placental abruption, syndrome of Hemolysis, Elevated Liver enzymes and Low Platelets (HELLP) and ultimately even neonatal or m...